// App-Quantinova.ai

3028 : Diagnostic PD-L1 immunohistochemistry in NSCLC: Results of the first German harmonization study.

Researchers

Presenter

  • Andreas H. Scheel

Principal Investigators

  • Manfred Dietel

  • Lukas C. Heukamp

  • Korinna Johrens

  • Thomas Kirchner

  • Simone Reu

  • Josef Ruschoff

  • Hans-Ulrich Schildhaus

  • Peter Schirmacher

  • Markus Tiemann

  • Arne Warth

  • Wilko Weichert

  • Rieke Nila Fischer

  • Juergen Wolf

  • Reinhard Buettner

Medical Centers

  • Institute of Pathology, University Hospital of Cologne, Cologne, Germany

  • Institute of Pathology, Charite Universitatsmedizin Berlin, Berlin, Germany

  • Hematopathology Hamburg, Hamburg, Germany

  • Institute of Pathology, Charite University Medicine, Campus Berlin-Mitte, Berlin, Germany

  • Department of Pathology, University of Munich, Muenchen, Germany

  • LMU Munich, Institute of Pathology, Munich, Germany

  • Institut fur Pathologie Nordhessen and Targos Molecular Pathology GmbH, Kassel, Germany

  • Institute of Pathology, University Hospital Gottingen, Gottingen, Germany

  • Pathologisches Institut Universitat Heidelberg, Heidelberg, Germany

  • LMU Munich, Institute of Pathology, Munich, Germany

  • Lung Cancer Group Cologne, Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital Cologne, Cologne, Germany

  • Department 1 for Internal Medicine, Center for Integrated Oncology Koln-Bonn, University Hospital Cologne, Cologne, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • SP263

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved